Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

CymaBay Therapeutics Q4 EPS $(0.34) Misses $(0.26) Estimate

CymaBay Therapeutics (NASDAQ:CBAY) reported quarterly losses of $(0.34) per share which missed the analyst consensus estimate of $(0.26) by 30.77 percent. This is a 47.83 percent decrease over losses of $(0.23) per share
byBenzinga Newsdesk
March 17, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

CymaBay Therapeutics (NASDAQ:CBAY) reported quarterly losses of $(0.34) per share which missed the analyst consensus estimate of $(0.26) by 30.77 percent. This is a 47.83 percent decrease over losses of $(0.23) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts